Neerjesh P, Rajkishor Singh, Vipender Singh Chopra, Dharti N, Kavita Dhar and Sanjay Kumar Singh 2015. Would other oral hypoglycaemics persist as an adequate 1ST line add-on therapy to metformin in patients with type 2 diabetes mellitus? No, it’s time to refocus!. World Journal of Pharmaceutical Sciences. 3, 12 (Dec. 2015), 2444–2451.